-
1
-
-
0019861205
-
Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
-
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529-1533.
-
(1981)
N Engl J Med
, vol.304
, pp. 1529-1533
-
-
Weiden, P.L.1
Sullivan, K.M.2
Flournoy, N.3
Storb, R.4
Thomas, E.D.5
-
2
-
-
0023690307
-
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion
-
Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.. Ann Intern Med 1988; 108: 806-814.
-
(1988)
Ann Intern Med
, vol.108
, pp. 806-814
-
-
Goldman, J.M.1
Gale, R.P.2
Horowitz, M.M.3
Biggs, J.C.4
Champlin, R.E.5
Gluckman, E.6
-
3
-
-
0025678601
-
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
-
Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
-
(1990)
Blood
, vol.76
, pp. 2462-2465
-
-
Kolb, H.J.1
Mittermuller, J.2
Clemm, C.3
Holler, E.4
Ledderose, G.5
Brehm, G.6
-
4
-
-
0033832579
-
Donor leukocyte infusions in acute lymphocytic leukemia
-
Collins Jr RH, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant 2000; 26: 511-516.
-
(2000)
Bone Marrow Transplant
, vol.26
, pp. 511-516
-
-
Collins Jr, R.H.1
Goldstein, S.2
Giralt, S.3
Levine, J.4
Porter, D.5
Drobyski, W.6
-
5
-
-
2942712161
-
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
-
Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
-
(1997)
J Clin Oncol
, vol.15
, pp. 433-444
-
-
Collins Jr, R.H.1
Shpilberg, O.2
Drobyski, W.R.3
Porter, D.L.4
Giralt, S.5
Champlin, R.6
-
6
-
-
0034667532
-
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
-
Dazzi F, Szydlo RM, Cross NC, Craddock C, Kaeda J, Kanfer E et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2000; 96: 2712-2716.
-
(2000)
Blood
, vol.96
, pp. 2712-2716
-
-
Dazzi, F.1
Szydlo, R.M.2
Cross, N.C.3
Craddock, C.4
Kaeda, J.5
Kanfer, E.6
-
7
-
-
0037100284
-
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose
-
Guglielmi C, Arcese W, Dazzi F, Brand R, Bunjes D, Verdonck LF et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose. Blood 2002; 100 397-405.
-
(2002)
Blood
, vol.100
, pp. 397-405
-
-
Guglielmi, C.1
Arcese, W.2
Dazzi, F.3
Brand, R.4
Bunjes, D.5
Verdonck, L.F.6
-
8
-
-
0033844816
-
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome
-
Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MH, Fibbe W, Russell I et al. Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome. J Clin Oncol 2000; 18: 3031-3037.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3031-3037
-
-
Lokhorst, H.M.1
Schattenberg, A.2
Cornelissen, J.J.3
van Oers, M.H.4
Fibbe, W.5
Russell, I.6
-
9
-
-
0034651931
-
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
-
Porter DL, Collins Jr RH, Hardy C, Keman NA, Drobyski WR, Giralt S et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214-1221.
-
(2000)
Blood
, vol.95
, pp. 1214-1221
-
-
Porter, D.L.1
Collins Jr, R.H.2
Hardy, C.3
Keman, N.A.4
Drobyski, W.R.5
Giralt, S.6
-
10
-
-
0033665539
-
Donor leukocyte infusions for multiple myeloma
-
Salama M, Nevill T, Marcellus D, Parker P, Johnson M, Kirk A et al. Donor leukocyte infusions for multiple myeloma. Bone Marrow Transplant 2000; 26: 1179-1184.
-
(2000)
Bone Marrow Transplant
, vol.26
, pp. 1179-1184
-
-
Salama, M.1
Nevill, T.2
Marcellus, D.3
Parker, P.4
Johnson, M.5
Kirk, A.6
-
11
-
-
0028237517
-
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse
-
van Rhee F, Lin F, Cullis JO, Spencer A, Cross NC, Chase A et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-3383.
-
(1994)
Blood
, vol.83
, pp. 3377-3383
-
-
van Rhee, F.1
Lin, F.2
Cullis, J.O.3
Spencer, A.4
Cross, N.C.5
Chase, A.6
-
12
-
-
0029100438
-
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
-
Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
-
(1995)
Blood
, vol.86
, pp. 2041-2050
-
-
Kolb, H.J.1
Schattenberg, A.2
Goldman, J.M.3
Hertenstein, B.4
Jacobsen, N.5
Arcese, W.6
-
13
-
-
0032982237
-
In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion
-
Schattenberg A, Schaap N, Van De Wiel-Van Kemenade E, Bar B, Preijers F, Van Der Maazen R et al. In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion. Leuk Lymphoma 1999; 32: 317-325.
-
(1999)
Leuk Lymphoma
, vol.32
, pp. 317-325
-
-
Schattenberg, A.1
Schaap, N.2
Van De Wiel-Van Kemenade, E.3
Bar, B.4
Preijers, F.5
Van Der Maazen, R.6
-
14
-
-
33644886960
-
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions
-
Huff CA, Fuchs EJ, Smith BD, Blackford A, Garrett-Mayer E, Brodsky RA et al. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant 2006; 12: 414-421.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 414-421
-
-
Huff, C.A.1
Fuchs, E.J.2
Smith, B.D.3
Blackford, A.4
Garrett-Mayer, E.5
Brodsky, R.A.6
-
15
-
-
0029092530
-
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease
-
Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
-
(1995)
Blood
, vol.86
, pp. 1261-1268
-
-
Mackinnon, S.1
Papadopoulos, E.B.2
Carabasi, M.H.3
Reich, L.4
Collins, N.H.5
Boulad, F.6
-
16
-
-
0030831669
-
Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse
-
Savage DG, Szydlo RM, Chase A, Apperley JF, Goldman JM. Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol 1997; 99: 30-35.
-
(1997)
Br J Haematol
, vol.99
, pp. 30-35
-
-
Savage, D.G.1
Szydlo, R.M.2
Chase, A.3
Apperley, J.F.4
Goldman, J.M.5
-
17
-
-
0028863238
-
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient
-
Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F et al. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient. Blood 1995; 86: 3590-3597.
-
(1995)
Blood
, vol.86
, pp. 3590-3597
-
-
Spencer, A.1
Szydlo, R.M.2
Brookes, P.A.3
Kaminski, E.4
Rule, S.5
van Rhee, F.6
-
18
-
-
13344250478
-
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction
-
Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F et al. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549-1555.
-
(1996)
Blood
, vol.87
, pp. 1549-1555
-
-
Hochhaus, A.1
Lin, F.2
Reiter, A.3
Skladny, H.4
Mason, P.J.5
van Rhee, F.6
-
19
-
-
0042744710
-
Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib
-
Lin F, Drummond M, O'Brien S, Cervantes F, Goldman J, Kaeda J. Molecular monitoring in chronic myeloid leukemia patients who achieve complete cytogenetic remission on imatinib. Blood 2003; 102: 1143.
-
(2003)
Blood
, vol.102
, pp. 1143
-
-
Lin, F.1
Drummond, M.2
O'Brien, S.3
Cervantes, F.4
Goldman, J.5
Kaeda, J.6
-
20
-
-
33646590620
-
Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: An attempt to define patients who may not require further therapy
-
Kaeda J, O'Shea D, Szydlo RM, Olavarria E, Dazzi F, Marin D et al. Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: An attempt to define patients who may not require further therapy. Blood 2006; 107:4171-4176.
-
(2006)
Blood
, vol.107
, pp. 4171-4176
-
-
Kaeda, J.1
O'Shea, D.2
Szydlo, R.M.3
Olavarria, E.4
Dazzi, F.5
Marin, D.6
-
21
-
-
0024694111
-
Proposals for standardized reporting of results of bone marrow transplantation for leukaemia
-
Clift R, Goldman J, Gratwohl A, Horowitz M. Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. Bone Marrow Transplant 1989; 4: 445-448.
-
(1989)
Bone Marrow Transplant
, vol.4
, pp. 445-448
-
-
Clift, R.1
Goldman, J.2
Gratwohl, A.3
Horowitz, M.4
-
22
-
-
0033962014
-
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
-
Dazzi F, Szydlo RM, Craddock C, Cross NC, Kaeda J, Chase A et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67-71.
-
(2000)
Blood
, vol.95
, pp. 67-71
-
-
Dazzi, F.1
Szydlo, R.M.2
Craddock, C.3
Cross, N.C.4
Kaeda, J.5
Chase, A.6
-
23
-
-
0027275074
-
Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
-
Cross NC, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1936.
-
(1993)
Blood
, vol.82
, pp. 1929-1936
-
-
Cross, N.C.1
Feng, L.2
Chase, A.3
Bungey, J.4
Hughes, T.P.5
Goldman, J.M.6
-
24
-
-
0016187133
-
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
-
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
-
(1974)
Transplantation
, vol.18
, pp. 295-304
-
-
Glucksberg, H.1
Storb, R.2
Fefer, A.3
Buckner, C.D.4
Neiman, P.E.5
Clift, R.A.6
-
25
-
-
0031470510
-
The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation
-
Raanani P, Dazzi F, Sohal J, Szydlo RM, van Rhee F, Reiter A et al. The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation. Br J Haematol 1997; 99: 945-950.
-
(1997)
Br J Haematol
, vol.99
, pp. 945-950
-
-
Raanani, P.1
Dazzi, F.2
Sohal, J.3
Szydlo, R.M.4
van Rhee, F.5
Reiter, A.6
-
26
-
-
0032544083
-
+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation
-
+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 1998; 95: 10152-10157.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 10152-10157
-
-
Smit, W.M.1
Rijnbeek, M.2
van Bergen, C.A.3
Fibbe, W.E.4
Willemze, R.5
Falkenburg, J.H.6
-
27
-
-
30944446623
-
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
-
Russell NH, Byrne JL, Faulkner RD, Gilyead M, Das-Gupta EP, Haynes AP. Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005; 36: 437-441.
-
(2005)
Bone Marrow Transplant
, vol.36
, pp. 437-441
-
-
Russell, N.H.1
Byrne, J.L.2
Faulkner, R.D.3
Gilyead, M.4
Das-Gupta, E.P.5
Haynes, A.P.6
-
28
-
-
0027465548
-
Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation
-
Schwarer AP, Jiang YZ, Brookes PA, Barrett AJ, Batchelor JR, Goldman JM et al. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203-205.
-
(1993)
Lancet
, vol.341
, pp. 203-205
-
-
Schwarer, A.P.1
Jiang, Y.Z.2
Brookes, P.A.3
Barrett, A.J.4
Batchelor, J.R.5
Goldman, J.M.6
-
29
-
-
0037418284
-
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
-
Marijt WA, Heemskerk MH, Kloosterboer FM, Goulmy E, Kester MG, van der Hoorn MA et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742-2747.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 2742-2747
-
-
Marijt, W.A.1
Heemskerk, M.H.2
Kloosterboer, F.M.3
Goulmy, E.4
Kester, M.G.5
van der Hoorn, M.A.6
-
30
-
-
0141613838
-
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
-
Olavarria E, Ottmann OG, Deininger M, Clark RE, Bandini G, Byrne J et al. Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 2003; 17: 1707-1712.
-
(2003)
Leukemia
, vol.17
, pp. 1707-1712
-
-
Olavarria, E.1
Ottmann, O.G.2
Deininger, M.3
Clark, R.E.4
Bandini, G.5
Byrne, J.6
-
31
-
-
33744503915
-
A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation
-
Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ. A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation. Haematologica 2006; 91 663-666.
-
(2006)
Haematologica
, vol.91
, pp. 663-666
-
-
Weisser, M.1
Tischer, J.2
Schnittger, S.3
Schoch, C.4
Ledderose, G.5
Kolb, H.J.6
-
32
-
-
28544440836
-
Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation
-
Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ. Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1009-1015.
-
(2005)
Bone Marrow Transplant
, vol.36
, pp. 1009-1015
-
-
Savani, B.N.1
Montero, A.2
Kurlander, R.3
Childs, R.4
Hensel, N.5
Barrett, A.J.6
|